Key highlights from Sun Pharmaceutical Industries Limited (SUNPHARMA) Q2 FY23 Earnings Concall Q&A Highlights: [00:16:46] Tushar Manudhane of Motilal Oswal asked about
Sun Pharmaceutical Industries Limited Q2 FY23 Earnings Conference Call Insights
Categories
pharmaceuticals
Sun Pharmaceutical Industries Limited (SUNPHARMA) Q2 FY23 Earnings Concall Transcript
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Q2 FY23 Earnings Concall dated Nov. 01, 2022 Corporate Participants: Nimish Desai -- Investor Relations Dilip S.
Dr. Reddy’s Laboratories Limited Q2FY23; Net Profit Increased By 12%
Dr. Reddy's Laboratories Limited (NSE: DRREDDY) reported Revenue from Operations for Q2 FY23 of ₹63,318 Crore up from ₹57,896 Crore year on
Dr. Reddy’s Laboratories (DRREDDY) Q2 FY23 Earnings Concall Transcript
Dr. Reddy's Laboratories (NSE: DRREDDY) Q2 FY23 Earnings Concall dated Oct. 28, 2022 Corporate Participants: Amit Agarwal -- Head of Investor Relations
Glenmark Life Sciences Limited Q2 FY23 Earnings Conference Call Insights
https://youtu.be/FHgUfHa30gw Key highlights from Glenmark Life Sciences Limited (GLS) Q2 FY23 Earnings Concall Management Update: [00:02:53] GLS said that the demand softness
Gland Pharma Limited Q2 FY23 Earnings Conference Call Insights
https://youtu.be/4X77Cs34eLo Key highlights from Gland Pharma Limited (GLAND) Q2 FY23 Earnings Concall Management Update: [00:02:23] GLAND said it saw improvement in supplies
Torrent Pharmaceuticals Ltd Q2 FY23 Earnings Conference Call Insights
Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q2 FY23 Earnings Concall Q&A Highlights: [00:06:41]Damayanti Kerai from HSBC asked about split of India
Jubilant Pharmova reports dip in its net profit by 97% for Q2FY23
Jubilant Pharmova reported total income of INR 1,599.5 crores during the period ended September 30, 2022 as compared to INR 1,657.7 crores
Jubilant Pharmova Limited (JUBLPHARMA) Q2 FY23 Earnings Concall Transcript
Jubilant Pharmova Limited (NSE:JUBLPHARMA) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Surajit Pal -- Head, Investor Relations Shyam S
Torrent Pharmaceuticals Ltd (TORNTPHARM) Q2 FY23 Earnings Concall Transcript
Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Sudhir Menon -- Chief Financial Officer & Executive
Glenmark Life Sciences Limited (GLS) Q2 FY23 Earnings Concall Transcript
Glenmark Life Sciences Limited (NSE:GLS) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Soumi Rao -- Head - Corporate Communications
Aarti Industries Ltd – All that you need to know about this multibagger stock in one article
About Company: Established in 1984, Aarti Industries is a leading Indian manufacturer of Speciality Chemicals and Pharmaceuticals with a global footprint. Chemicals
Dr. Reddy’s Laboratories (DRREDDY) FY23 Earnings Concall Transcript
Dr. Reddy's Laboratories (NSE:DRREDDY) FY23 Earnings Concall dated Oct. 13, 2022 Corporate Participants: Francisco Betti -- Head of Shaping the Future of Advanced Manufacturing
Everything you need to know about Jubilant Pharmova
About Company and its Outlook: Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research
Jubilant Pharmova reports dip in its net profit by 71% for Q1FY23
Jubilant Pharmova reported total income of INR 1,452 crores during the period ended June 30, 2022 as compared to INR 1,635 crores
Panacea Biotech Q1FY23 Net profit soars by 2%
Panacea Biotec reported total income of INR 111 crores during the period ended June 30, 2022 as compared to INR 132 crores
Balaxi Pharmaceuticals Ltd Q1 FY23 Earnings Conference Call Insights
Key highlights from Balaxi Pharmaceuticals Ltd (BALAXI) Q1 FY23 Earnings Concall Q&A Highlights: [00:06:25] Archana Gude with IDBI asked about the sustainable
SMS Pharmaceuticals Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/G2_d7tTye3s Key highlights from SMS Pharmaceuticals Limited (SMSPHARMA) Q1 FY23 Earnings Concall Q&A Highlights: Atul Kothari from Progwell Securities asked about the
Top 5 Stocks with 200% Profit Growth in 2022
1. India Cements Ltd India Cements Ltd is a leading cement manufacturing company based in Chennai. It was founded in 1946 by
Gufic Biosciences Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/l4VNZKKcWGw Key highlights from Gufic Biosciences Limited (GUFICBIO) Q1 FY23 Earnings Concall Q&A Highlights: Girish Gulati asked about pancreatic cancer update and
Aurobindo Pharma Limited Q1 FY23 Earnings Conference Call Insights
https://youtu.be/b8g7f6BUs9Y Key highlights from Aurobindo Pharma Limited (AUROPHARMA) Q1 FY23 Earnings Concall Q&A Highlights: [00:08:34] Prakash Agarwal of Axis Capital asked about